1. Home
  2. ZVIA vs SGMT Comparison

ZVIA vs SGMT Comparison

Compare ZVIA & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVIA
  • SGMT
  • Stock Information
  • Founded
  • ZVIA 2007
  • SGMT 2006
  • Country
  • ZVIA United States
  • SGMT United States
  • Employees
  • ZVIA N/A
  • SGMT N/A
  • Industry
  • ZVIA Beverages (Production/Distribution)
  • SGMT
  • Sector
  • ZVIA Consumer Staples
  • SGMT
  • Exchange
  • ZVIA Nasdaq
  • SGMT Nasdaq
  • Market Cap
  • ZVIA 227.3M
  • SGMT 269.2M
  • IPO Year
  • ZVIA 2021
  • SGMT 2023
  • Fundamental
  • Price
  • ZVIA $2.92
  • SGMT $7.67
  • Analyst Decision
  • ZVIA Buy
  • SGMT Strong Buy
  • Analyst Count
  • ZVIA 4
  • SGMT 8
  • Target Price
  • ZVIA $4.61
  • SGMT $27.25
  • AVG Volume (30 Days)
  • ZVIA 711.9K
  • SGMT 774.2K
  • Earning Date
  • ZVIA 08-06-2025
  • SGMT 08-13-2025
  • Dividend Yield
  • ZVIA N/A
  • SGMT N/A
  • EPS Growth
  • ZVIA N/A
  • SGMT N/A
  • EPS
  • ZVIA N/A
  • SGMT N/A
  • Revenue
  • ZVIA $158,371,000.00
  • SGMT N/A
  • Revenue This Year
  • ZVIA $5.72
  • SGMT N/A
  • Revenue Next Year
  • ZVIA $6.83
  • SGMT N/A
  • P/E Ratio
  • ZVIA N/A
  • SGMT N/A
  • Revenue Growth
  • ZVIA N/A
  • SGMT N/A
  • 52 Week Low
  • ZVIA $0.90
  • SGMT $1.73
  • 52 Week High
  • ZVIA $4.99
  • SGMT $11.41
  • Technical
  • Relative Strength Index (RSI)
  • ZVIA 41.60
  • SGMT 39.43
  • Support Level
  • ZVIA $2.84
  • SGMT $8.62
  • Resistance Level
  • ZVIA $3.63
  • SGMT $10.06
  • Average True Range (ATR)
  • ZVIA 0.23
  • SGMT 0.74
  • MACD
  • ZVIA -0.04
  • SGMT -0.17
  • Stochastic Oscillator
  • ZVIA 10.15
  • SGMT 0.38

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: